======= NOC3L ======= == Gene Information == * **Official Symbol**: NOC3L * **Official Name**: NOC3 like DNA replication regulator * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=64318|64318]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WTT2|Q8WTT2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NOC3L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NOC3L|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610769|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May be required for adipogenesis. {ECO:0000250}. |NOC3p| |CBF| |fat cell differentiation| |chromatin binding| |nuclear speck| |nucleolus| |mitochondrion| |RNA binding| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|-2.65| |[[:results:exp390|Pifithrin-alpha 20μM R07 exp390]]|-2.58| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|-2.48| |[[:results:exp494|Isoniazid 100μM R08 exp494]]|-2.42| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-2.28| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|-2.2| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-2.17| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|-1.97| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|-1.93| |[[:results:exp449|Arsenic trioxide 60μM R08 exp449]]|-1.85| |[[:results:exp358|FK-506 5μM R07 exp358]]|-1.83| |[[:results:exp275|Citral 75μM R06 exp275]]|-1.82| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|-1.81| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-1.8| |[[:results:exp483|FTY720 3μM R08 exp483]]|-1.73| |[[:results:exp539|42°C R08 exp539]]|-1.71| |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-1.7| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|1.75| |[[:results:exp464|Calcipotriol 5μM R08 exp464]]|1.76| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|1.81| |[[:results:exp10|CCCP 0.1μM R00 exp10]]|1.88| |[[:results:exp382|Palbociclib 1μM R07 exp382]]|1.91| |[[:results:exp134|MS023 2μM R03 exp134]]|2.41| |[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|2.42| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|2.46| |[[:results:exp177|Apcin 25μM plus proTAME 2μM R04 exp177]]|2.87| ^Gene^Correlation^ |[[:human genes:p:polr2j3|POLR2J3]]|0.426| Global Fraction of Cell Lines Where Essential: 717/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|27/28| |bone|26/26| |breast|30/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|15/16| |kidney|21/21| |liver|19/20| |lung|74/75| |lymphocyte|16/16| |ovary|25/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|14/15| |prostate|1/1| |skin|24/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|21/22| |urinary tract|28/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1432 * **Expression level (log2 read counts)**: 6.11 {{:chemogenomics:nalm6 dist.png?nolink |}}